// App-Quantinova.ai

2334 : Anti-cancer efficacy of the combination with immunomodulatory antibodies and MEK inhibitor for Kras mutation and p53 knockout driven lung cancer

Researchers

Presenter

  • Jong Woo Lee

Principal Investigators

  • Yu Zhang

  • Hee Sun Park

  • Sin Aye Park

  • Ja Seok Peter Koo

  • Roy S. Herbst

Medical Centers

  • Yale University School of Medicine, New Haven, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Melanoma

  • Solid malignancies

Biomarkers

  • p53

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved